Investor Presentation

Date: September 28, 2026 National Stock Exchange of India Ltd., BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra (E), Mumbai – 400 051 Mumbai- 400001 NSE Scrip Symbol: PRASOLCHEM BSE Scrip Code: 544912 Dear Sir/Madam, Sub: Submission of Presentation of Quarterly Earnings Conference Call pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulation 30 of the Listing Regulations, please find enclosed herewith the Q1 FY27 Results Presentation of the Company for your records. Further, this intimation is also uploaded on the Company’s website https://www.prasolchem.com/investor- relations/ Note: No Unpublished Price Sensitive Information will be shared during the call and Date and participants of the aforesaid meet is subject to change due to exigencies on the part of Organisers/ Investors/ Analysts/ Company/ Participants. We request you to please take the same on record. Thanking You, Yours Sincerely, FOR PRASOL CHEMICALS LIMITED KIRAN RAJENDRA AGRAWAL Company Secretary & Compliance Officer Membership No. : A13188 Prasol Chemicals Limited Investor Presentation | Q1 FY27 | September 2026 Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Prasol Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment what so ever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections. Q1FY27 Performance Highlights Successful IPO Listing on 16th September 2026 Chairman’s Message “We are delighted to begin our journey as a listed company on the Indian stock exchanges. For an Indian entrepreneur, this is a dream come true. It is a landmark moment that reflects more than three decades of effort by our team, and it marks the start of an exciting new chapter. I would like to thank all our employees, suppliers, customers and other stakeholders for their continued trust, support and partnership over the years . Q1 FY27 has been a strong start to the new financial year, with a highest ever quarterly performance on many key parameters. We delivered healthy year-on-year revenue growth, driven by better realisations, higher volumes and an improving product mix. We witnessed sustainable improvement in utilizations at Mahad facility which has led to turnaround in profitability resulting in overall uptick in EBITDA margins. Demand across our Acetone-based and Phosphorous-based products remained healthy despite external challenges. Over the decades, we have deliberately built a business that is diversified across industries, products and geographies, and serves more than 1,600 customers. Our pipeline is equally robust: we are developing more than 40 new products at various stages, and we expect several of them to be commercialised in the coming years. We will keep investing in phases to expand our capabilities across both existing and new products. We are a company with deeper chemistry with forward and backward integration and a stronger moat across Mr. Nishith Shah, diversified applications. With turnaround of Mahad facility to profitable trajectory, higher contribution of secondary and tertiary products, capex investments in existing product line to the tune of Rs. 300 crores along Chairman & Whole Time Director with planned foray in new products with new end industries, we are on a journey of sustained profitability for Prasol. We expect FY27 revenue of Rs 1,550–1,650 crores, with EBITDA of Rs. 240-250 crores excluding price fluctuations due to geopolitical-led supply chain issues and forex gains/ losses if any.” Highest Ever Quarterly Performance Financial performance • Total revenue was Rs 433.6 crores, a growth of 36% YoY basis. Growth came from steady volume growth, a better product mix and higher realisations. • EBITDA was Rs 90.3 crore, up 122% YoY, with a margin of 20.8%. The margins were positively impacted due to average selling price increase on account of geopolitical-led supply chain issues to the tune of Rs 25 crores and Rs. 0.92 crores on account of foreign currency fluctuations - expect normalisation in the coming quarters. • Profit after tax was Rs 61.0 crores for the quarter, a growth of 151% on YoY basis. Business performance • Domestic sales grew strongly in both value and volume, backed by healthy demand for our value-added products. • Exports grew year-on-year. However, the geopolitical tensions due to the West Asia conflict held back shipments. • Product mix improved as secondary and tertiary derivatives grew in both the acetone and phosphorus value chain. Operations and Expansion • Mahad had its best-ever quarterly production, and capacity utilisation improved • Continue to focus on efficiency, cost reduction and better yields for selected products. • Capacity expansion at both locations is on schedule. Q1FY27 Performance Highlights (INR in crores) Total Revenue Gross Profit 30.0% 37.9% Margin +36% +72% 433.6 164.5* 319.6 25.0 95.8 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 EBITDA Profit After Tax 12.7% 20.8% 7.6% 14.1% Margin +122% +151% 90.3 61.0 25.0 40.6 24.3 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 *Due to geopolitical-led supply chain issues, there was a sharp increase in Average Selling Price to the tune of Rs. 25 crores in Gross Profit during Q1FY27. Additionally there is a Rs. 0.92 crore positive impact due to Foreign Currency fluctuations 7 Structured Uptick in Margins Over the Years (INR crores) FY11 - FY15 FY16 - FY19 FY20 - FY26 Avg Gross Margin 30% 26.1% 28.5% 30.7% 37.9% Margin M 378.7 Avg Gross Margin 26% 288.1 o 228.7 r G 164.5 COGEN Added in 2019 FY2 [Showing first 8,000 characters — download PDF for full document]